Bone Health Technologies Raises $5M for Osteopenia Care
HIT Consultant
MARCH 6, 2024
This influx of capital marks a pivotal moment in BHT’s mission to reshape bone health for postmenopausal women, closing right in time for de novo FDA clearance. Ella Seitz of Esplanade Ventures and Yushin Yazaki of Terumo were appointed as board observers.
Let's personalize your content